• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19, ECMO, and lymphopenia: a word of caution.

作者信息

Henry Brandon Michael

机构信息

Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA; Pediatric COVID-19 Open Data Analysis Group, Cincinnati, OH, USA.

出版信息

Lancet Respir Med. 2020 Apr;8(4):e24. doi: 10.1016/S2213-2600(20)30119-3. Epub 2020 Mar 13.

DOI:10.1016/S2213-2600(20)30119-3
PMID:32178774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118650/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/7118650/c713bb874946/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/7118650/c713bb874946/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/7118650/c713bb874946/fx1_lrg.jpg

相似文献

1
COVID-19, ECMO, and lymphopenia: a word of caution.新型冠状病毒肺炎、体外膜肺氧合与淋巴细胞减少：一则警示
Lancet Respir Med. 2020 Apr;8(4):e24. doi: 10.1016/S2213-2600(20)30119-3. Epub 2020 Mar 13.
2
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.中国危重症新冠肺炎患者使用体外膜肺氧合（ECMO）治疗的预后：一项回顾性病例系列研究。
Crit Care. 2020 Apr 15;24(1):148. doi: 10.1186/s13054-020-2840-8.
3
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).体外膜肺氧合（ECMO）在 2019 冠状病毒病（COVID-19）肺炎和急性呼吸窘迫综合征（ARDS）危重症患者中的应用。
Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364.
4
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?体外膜肺氧合（ECMO）：在治疗严重 COVID-19 中是否有作用？
Int J Infect Dis. 2020 May;94:78-80. doi: 10.1016/j.ijid.2020.03.058. Epub 2020 Apr 3.
5
Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.2019冠状病毒病（COVID-19）：中国以外地区的重症监护视角
Anaesth Crit Care Pain Med. 2020 Apr;39(2):167-169. doi: 10.1016/j.accpm.2020.03.001. Epub 2020 Mar 3.
6
ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?用于治疗与新型冠状病毒肺炎相关的重症急性呼吸窘迫综合征的体外膜肺氧合：现在我们知道我们可以做到，但我们应该这么做吗？
Lancet Respir Med. 2020 Nov;8(11):1066-1068. doi: 10.1016/S2213-2600(20)30357-X. Epub 2020 Aug 13.
7
[Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation].新型冠状病毒肺炎疫情期间体外膜肺氧合院际转运的研究：基于6例体外膜肺氧合治疗的重症甲型H1N1流感病毒肺炎患者的转运经验
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):430-434. doi: 10.3760/cma.j.cn121430-20200309-00413.
8
Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort!体外膜肺氧合治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征重症患者：值得付出努力！
Am J Respir Crit Care Med. 2020 Nov 15;202(10):1477-1479. doi: 10.1164/rccm.202006-2505LE.
9
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019.COVID-19 危重症患者的静脉-动脉-静脉体外膜肺氧合。
Medicina (Kaunas). 2020 Sep 30;56(10):510. doi: 10.3390/medicina56100510.
10
ECMO for ARDS due to COVID-19.用于治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征的体外膜肺氧合
Heart Lung. 2020 Jul-Aug;49(4):348-349. doi: 10.1016/j.hrtlng.2020.03.012. Epub 2020 Mar 26.

引用本文的文献

1
Inflammatory cytokine-primed MSC-derived extracellular vesicles ameliorate acute lung injury via enhanced immunomodulation and alveolar repair.炎症细胞因子预处理的间充质干细胞衍生的细胞外囊泡通过增强免疫调节和肺泡修复改善急性肺损伤。
Stem Cell Res Ther. 2025 Aug 22;16(1):450. doi: 10.1186/s13287-025-04576-z.
2
Utility of Hematological and Biochemical Parameters as a Screening Tool for Assessing Coronavirus Disease 2019 Infection and its Severity.血液学和生化参数作为评估2019冠状病毒病感染及其严重程度的筛查工具的效用
J Microsc Ultrastruct. 2023 Jan 19;12(4):214-220. doi: 10.4103/jmau.jmau_59_22. eCollection 2024 Oct-Dec.
3

本文引用的文献

1
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
2
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
3
Extracorporeal membrane oxygenation (ECMO) in patients with severe COVID-19 adult respiratory distress syndrome: a systematic review and meta-analysis.
体外膜肺氧合（ECMO）用于重症新型冠状病毒肺炎成人呼吸窘迫综合征患者：一项系统评价与荟萃分析
Cardiothorac Surg. 2021;29(1):9. doi: 10.1186/s43057-021-00046-3. Epub 2021 Apr 12.
4
Predicting COVID-19 Re-Positive Cases in Malnourished Older Adults: A Clinical Model Development and Validation.预测营养不良的老年 COVID-19 复阳病例：临床模型的建立和验证。
Clin Interv Aging. 2024 Mar 9;19:421-437. doi: 10.2147/CIA.S449338. eCollection 2024.
5
Mesenchymal stem cells-based therapies for severe ARDS with ECMO: a review.基于间充质干细胞的体外膜肺氧合治疗重症急性呼吸窘迫综合征的综述
Intensive Care Med Exp. 2024 Feb 9;12(1):12. doi: 10.1186/s40635-024-00596-w.
6
The Evaluation of Hematological Parameters and Their Correlation with Disease Prognosis in COVID-19 Disease in Iran.伊朗COVID-19疾病血液学参数评估及其与疾病预后的相关性
Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):89-99. doi: 10.18502/ijhoscr.v17i2.12645.
7
Extracorporeal Membrane Oxygenation for Severe COVID-19 in Indian Scenario: A Single Center Retrospective Study.印度背景下体外膜肺氧合治疗重症新型冠状病毒肺炎：一项单中心回顾性研究
Indian J Crit Care Med. 2023 Jun;27(6):381-385. doi: 10.5005/jp-journals-10071-24469.
8
Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal membrane oxygenation in the Middle Ruhr Region of Germany.德国中鲁尔地区有创和无创体外膜肺氧合治疗严重 COVID-19 相关呼吸衰竭的死亡率。
Sci Rep. 2023 Mar 29;13(1):5143. doi: 10.1038/s41598-023-31944-7.
9
Parameters to Predict the Outcome of Severe and Critical COVID-19 Patients when Admitted to the Hospital.预测重型和危重型新型冠状病毒肺炎患者入院时预后的参数
J Clin Med. 2023 Feb 7;12(4):1323. doi: 10.3390/jcm12041323.
10
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients.新冠病毒肺炎患者白细胞DNA损伤的临床研究
Curr Issues Mol Biol. 2023 Jan 19;45(2):963-974. doi: 10.3390/cimb45020062.
Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model.
连续性肾脏替代疗法可降低猪模型中静脉-静脉体外膜肺氧合引起的全身和肺部炎症。
Artif Organs. 2014 Mar;38(3):215-23. doi: 10.1111/aor.12154. Epub 2013 Dec 11.
4
Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults.新生儿、儿童和成人在体外膜肺氧合期间获得的感染。
Pediatr Crit Care Med. 2011 May;12(3):277-81. doi: 10.1097/PCC.0b013e3181e28894.
5
Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment.白细胞介素-6可能预测体外膜肺氧合治疗的生存率。
Perfusion. 2008 May;23(3):173-8. doi: 10.1177/0267659108097882.